3-Hydroxypyrazine-2-Carboxamide CAS 55321-99-8 Purity >98.0% (HPLC) Favipiravir Intermediate COVID-19
Favipiravir ya Ugavi wa Kibiashara na Viwango Vinavyohusiana:
Favipiravir CAS 259793-96-9
2-Aminopropanediamide CAS 62009-47-6
Diethyl Aminomalonate Hydrochloride CAS 13433-00-6
3,6-Dichloropyrazine-2-Carbonitrile CAS 356783-16-9
3,6-Difluoropyrazine-2-Carbonitrile CAS 356783-28-3
6-Fluoro-3-Hydroxypyrazine-2-Carbonitrile CAS 356783-31-8
6-Bromo-3-Hydroxypyrazine-2-Carboxamide CAS 259793-88-9
3-Hydroxypyrazine-2-Carboxamide CAS 55321-99-8
Jina la Kemikali | 3-Hydroxypyrazine-2-Carboxamide |
Visawe | T-1105;3-Hydroxy-2-Pyrazinecarboxamide;Favipiravir Desfluoro Uchafu;3-Oxo-3,4-dihydropyrazine-2-carboxamide |
Nambari ya CAS | 55321-99-8 |
Nambari ya CAT | RF-PI295 |
Hali ya Hisa | Katika Hisa, Uzalishaji Umeongezeka Hadi Kilo |
Mfumo wa Masi | C5H5N3O2 |
Uzito wa Masi | 139.11 |
Chapa | Ruifu Chemical |
Kipengee | Vipimo |
Mwonekano | Poda ya Manjano Isiyokolea hadi Hudhurungi |
Kitambulisho | IR, HPLC |
Kupoteza kwa Kukausha | <1.00% |
Uchafu Mmoja | <0.50% |
Vyuma Vizito | ≤20ppm |
Usafi | >98.0% (HPLC) |
Kiwango cha Mtihani | Kiwango cha Biashara |
Matumizi | Kati ya Favipiravir (CAS 259793-96-9) |
Kifurushi: Chupa, mfuko wa karatasi ya Alumini, 25kg/Ngoma, au kulingana na mahitaji ya mteja
Hali ya Uhifadhi:Hifadhi kwenye vyombo vilivyofungwa mahali pa baridi na kavu;Kinga kutoka kwa mwanga, unyevu
3-Hydroxypyrazine-2-Carboxamide (CAS 55321-99-8) ni uchafu wa kati au wa kati wa Favipiravir Intermediate (CAS 259793-96-9).Favipiravir ni dawa mpya ya kuzuia virusi yenye wigo mpana.Favipiravir inaweza kutumika kwa ajili ya kutibu mafua ya mafua A na B. Uchunguzi umeonyesha kuwa pamoja na virusi vya mafua, dawa hiyo pia inaonyesha shughuli nzuri ya kuzuia virusi dhidi ya aina mbalimbali za virusi vya RNA, kama vile virusi vya Ebola, virusi vya arena, virusi vya Bunia na kichaa cha mbwa. virusi.Wakati wa kuzuka kwa Ugonjwa mpya wa Coronavirus 2019 (COVID-19), Favipiravir inaweza kutumika katika matibabu ya wagonjwa walio na COVID-19 iliyopendekezwa na WHO.